News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

JPT Peptide Technologies GmbH and The Institute for Medical Immunology at the Charité in Berlin Announce Collaboration on Chronic Fatigue Syndrome


1/30/2013 9:43:40 AM

BERLIN--(BUSINESS WIRE)--JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), and The Institute for Medical Immunology at the Charité in Berlin today announced a collaborative agreement on the development of serological peptide markers for the differential diagnosis of chronic fatigue syndrome (CFS).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES